GRIFOLS | GRF

Stock Price
12.30
Daily Change
0.02 0.16%
Monthly
-3.98%
Yearly
32.17%
Q3 Forecast
12.21

Peers Price Chg Day Year Date
Alcon AG 64.08 0.62 0.98% -19.15% Sep/05
Almirall 10.96 -0.16 -1.44% 27.89% Sep/05
Amarin 15.33 0.30 2.00% 27.64% Sep/05
Amadeus IT 68.56 0.40 0.59% 11.33% Sep/05
argenx SE 639.80 8.40 1.33% 31.21% Sep/05
AstraZeneca 12,090.00 -98.00 -0.80% -4.89% Sep/06
Bayer 28.16 -0.42 -1.47% -1.83% Sep/06
Cie Automotive 27.20 0.15 0.55% 3.82% Sep/05
Essilor 259.60 -0.60 -0.23% 22.74% Sep/06
Ence Energia y Celulosa 2.82 0.01 0.43% -3.43% Sep/05
Ferrovial 46.96 0.06 0.13% 24.96% Sep/05
Fresenius Medical Care 41.99 0.28 0.67% 16.83% Sep/06
Fresenius 46.82 -0.36 -0.76% 39.22% Sep/06
Genmab 1,751.50 6.50 0.37% -5.83% Sep/05
Galapagos 28.44 1.84 6.92% 11.53% Sep/06
GRIFOLS 12.30 0.02 0.16% 32.17% Sep/05
GlaxoSmithKline 1,476.00 7.00 0.48% -10.63% Sep/05
Hikma Pharmaceutical 1,720.00 -3.00 -0.17% -12.07% Sep/05
Inditex 42.07 -0.60 -1.41% -9.62% Sep/06
Merck 109.55 1.05 0.97% -35.52% Sep/06
Novartis 103.98 0.06 0.06% 5.46% Sep/05
Philips 23.80 0.02 0.08% -12.63% Sep/06
Roche Holding 274.20 -1.50 -0.54% 2.62% Sep/06
Sanofi 79.50 0.54 0.68% -24.83% Sep/06
Smith & Nephew 1,416.00 6.00 0.43% 18.15% Sep/05
UCB 206.90 2.30 1.12% 28.99% Sep/05
Viscofan 60.80 0.20 0.33% 0.33% Sep/05
Demant 248.80 8.80 3.67% -11.27% Sep/05

Indexes Price Day Year Date
ES35 14851 -67.40 -0.45% 32.92% Sep/05
EU600 549 -0.88 -0.16% 8.42% Sep/05

GRIFOLS traded at 12.30 this Friday September 5th, increasing 0.02 or 0.16 percent since the previous trading session. Looking back, over the last four weeks, GRIFOLS gained 3.98 percent. Over the last 12 months, its price rose by 32.17 percent. Looking ahead, we forecast GRIFOLS to be priced at 12.21 by the end of this quarter and at 11.94 in one year, according to Trading Economics global macro models projections and analysts expectations.

Grifols SA is a Spain-based global specialty pharmaceutical company developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. It organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale and distribution of end products. Diagnostic focuses on researching, developing, manufacturing and marketing in vitro diagnostics products, such as analytical instruments, reagents and software, among others, for laboratories. Hospital offers technology and services for hospitals, clinics and specialized centers for the manufacture of medicines, as well as physiological saline solution, enteral nutritional fluids and medical devices for interventional therapy. Bio Supplies provides, mostly, biological products for non-therapeutic use. Others provides manufacturing services to third party companies.